arrow
刘

刘胜 (Sheng Liu)

Nankai University邮箱:shengliu@nankai.edu.cn
H指数:53
被引数:8,896

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic effects of nirmatrelvir/ritonavir on reducing complications of cardiac surgery, reinfection, and post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with previous SARS-CoV-2 infection: a randomized clinical trial (PEP Trial)

奈玛特韦/利托那韦在降低有既往SARS-CoV-2感染史患者的心脏手术并发症、再感染以及严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后急性期后遗症方面的预防效果:一项随机临床试验(PEP试验)

2025-04-110
PRE
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China

雾化或肌肉注射腺病毒5型载体COVID-19疫苗加强针的有效性:一项在中国进行的多中心、部分随机、平台试验

2025-03-260
OA